News
Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
Investing.com -- Mustang Bio Inc (NASDAQ: MBIO) stock surged over 78% after the U.S. Food and Drug Administration granted orphan drug designation to its MB-101 treatment for recurrent diffuse and ...
5h
InvestorsHub on MSNMustang Bio Shares Surge After FDA Grants Orphan Drug StatusMustang Bio Inc (NASDAQ:MBIO) stock soared over 78% following the U.S. Food and Drug Administration’s orphan drug designation for its MB-101 therapy targeting recurrent diffuse and anaplastic ...
4h
Stacker on MSNHow artificial intelligence is transforming medical imagingMUNGKHOOD STUDIO // ShutterstockHow artificial intelligence is transforming medical imagingA decade ago, deep learning ...
Mustang Bio makes the NASDAQ top percentage gainers list on FDA news, currently trading at $3.56. up $2.37, gaining 199% on volume of over 152 Million shares as of this report. The stock has a day's ...
Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approval from the Food and Drug ...
21hon MSN
The death toll from flash floods that raged through central Texas rose to 70 after searchers found more bodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results